🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tuan Vu

University of South Florida

ORCID: 0000-0003-0724-0210

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study”.

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

The Lancet Neurology(2023)10.1016/s1474-4422(23)00194-1

N/A

5.4DataRank · unranked

260 citations

Michael Benatar, Metin Kurtoğlu, Miloš D. Miljković, Nizar Chahin, Gregory Sahagian +37 more

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

New England Journal of Medicine(2020)10.1056/nejmoa1916945

N/A

4.8DataRank · unranked

529 citations

Eric A. Macklin, Suzanne Hendrix, James D. Berry, Michael A. Elliott, Samuel Maiser +54 more

Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial

Journal of Neurology Neurosurgery & Psychiatry(2022)10.1136/jnnp-2022-329024

N/A

2.3DataRank · unranked

66 citations

Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, James D. Berry, Michael A. Elliott +45 more

Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study

Therapeutic Advances in Neurological Disorders(2024)10.1177/17562864241243186

N/A

0.992DataRank · unranked

38 citations

Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma +23 more

Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis

Muscle & Nerve(2020)10.1002/mus.27091

N/A

0.781DataRank · unranked

182 citations

Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, Eric A. Macklin, James D. Berry +56 more

Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence

Neuropsychiatric Disease and Treatment(2023)10.2147/ndt.s374694

N/A

0.483DataRank · unranked

24 citations

Heinz Wiendl, Masahisa Katsuno, Stephen Reddel, James F. Howard, Tuan Vu

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

Annals of Clinical and Translational Neurology(2025)10.1002/acn3.70167

N/A

0.453DataRank · unranked

14 citations

Gregory Sahagian, Marc H. Feinberg, Charles A. Stewart, Christopher M. Jewell, Metin Kurtoğlu +6 more

In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al.

UNC Libraries(2024)10.17615/4bda-ea57

N/A

0DataRank · unranked

0 citations

Tuan Vu, Miloš D. Miljković, Susan Manzi, Tahseen Mozaffar, James F. Howard

Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis

Maryland Shared Open Access Repository (USMAI Consortium)(2025)10.13016/m2o2sh-xuyr

N/A

0DataRank · unranked

0 citations

Gregory Sahagian, Marc H. Feinberg, C. Andrew Stewart, Christopher M. Jewell, Metin Kurtoğlu +6 more

Clinical features of LRP4/agrin‐antibody–positive myasthenia gravis: A multicenter study

Muscle & Nerve(2020)10.1002/mus.26985

N/A

0DataRank · unranked

89 citations

Brandy Quarles, Jin‐Xiu Pan, Yu Zheng, James F. Howard, Andrea M. Corse +22 more

Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

The Lancet Rheumatology(2023)10.1016/s2665-9913(23)00003-6

N/A

0DataRank · unranked

55 citations

Anthony A. Amato, Mazen M. Dimachkie, Hector Chinoy, Yessar Hussain, James B Lilleker +43 more

Clinical significance of measuring hepatic venous pressure gradient on transjugular liver biopsy for patients with pre-cirrhotic bridging fibrosis liver disease

Clinical Imaging(2023)10.1016/j.clinimag.2023.02.004

N/A

0DataRank · unranked

3 citations

Hänel W. Eberly, Amy Zheng, Aidan Hintze, Kathryn McGillen, Jeffrey A. Cruz +2 more

Twelve-Month Follow-Up of Patients With Generalized Myasthenia Gravis Receiving BCMA-Directed mRNA Cell Therapy

medRxiv(2024)10.1101/2024.01.03.24300770

N/A

0DataRank · unranked

15 citations

Gregory Sahagian, Marc H. Feinberg, Charles A. Stewart, Christopher M. Jewell, Metin Kurtoğlu +5 more

Long-term Efficacy and Safety of Ravulizumab, a Long-acting Terminal Complement Inhibitor, in Adults With Anti-acetylcholine Receptor Antibody-positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open-label Extension

Neurology(2024)10.1212/01.wnl.0001051364.68802.aa

N/A

0DataRank · unranked

0 citations

Renato Mantegazza, Djillali Annane, Masahisa Katsuno, Andreas Meisel, Michael Nicolle +5 more

In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al.

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102918

N/A

0DataRank · unranked

0 citations

Susan Manzi, Miloš D. Miljković, Tuan Vu, Tahseen Mozaffar, James F. Howard